Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study. [electronic resource]
Producer: 20120522Description: 821-9 p. digitalISSN:- 1531-5053
- Administration, Oral
- Aged
- Alcoholism -- epidemiology
- Alendronate -- administration & dosage
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- epidemiology
- Bone Density Conservation Agents -- administration & dosage
- Case-Control Studies
- Cohort Studies
- Denmark -- epidemiology
- Diabetes Complications -- epidemiology
- Diphosphonates -- administration & dosage
- Drug Therapy -- statistics & numerical data
- Etidronic Acid -- administration & dosage
- Female
- Humans
- Jaw Diseases -- epidemiology
- Male
- Neoplasms -- epidemiology
- Organometallic Compounds -- administration & dosage
- Osteitis -- epidemiology
- Osteomyelitis -- epidemiology
- Osteoporosis -- drug therapy
- Parathyroid Hormone -- administration & dosage
- Periostitis -- epidemiology
- Radiotherapy -- statistics & numerical data
- Raloxifene Hydrochloride -- administration & dosage
- Risk Factors
- Sjogren's Syndrome -- epidemiology
- Strontium -- administration & dosage
- Thiophenes -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.